Boxer Capital focuses on investing in biotechnology companies aiming to drastically improve medicine, particularly for severe medical illnesses such as oncology and rare diseases. Their approach includes investing across the entire drug development lifecycle, from earlystage preclinical discovery assets to latestage clinical and commercial stage companies.